Documentos de Académico
Documentos de Profesional
Documentos de Cultura
GIGANTES
Caso clínico
OBJETIVOS
- Revisión de caso clínico
- Evaluación de manejo en quiste hepático
- Revisión de MBE
2
FILIACION
✘ FI: 10/09/18
✘ NOMBRE: S. B. D.
✘ EDAD 81 AÑOS
✘ SEXO: MASCULINO
✘ GI: PRIMARIA INCOMPLETA
✘ OCUPACION: MECANICO
✘ PROCEDENCIA: PUEBLO JOVEN - GUADALUPE
ENFERMEDAD ACTUAL
AFP 1.60
CEA 2.34
Amilasa 58
TGO - TGP 42 - 46 20 - 29
8
IMÁGENES
✘ CONCLUSIONES:
- DERRAME PLEURAL LAMINAR CON ANEUMATOSIS SUBYACENTE EN LAS BASES
PULMONARES.
- LIQUIDO LAMINAR EN GOTERAS PARIETOCOLICAS.
- POLIQUISTOSIS HEPATICA, ALGUNAS CON EFECTO DE MASA; COMPLICADA LA
UBICADA EN EL SEGMENTO IV.
12
13
14
15
16
17
18
19
21
22
23
24
25
26
27
29
30
31
FECHA EVOLUCIONES INDICACIONES
09/09/2018 1. Reposo
2. DB+LAV
3. CFV+BHE+SF+SNG+O2 húmedo para SatO2 >92%
4. NACL 09% a 30gotas
EVOLUCIÓN E INDICACIONES 5.
6.
Omeprazol 40mg EV C/24H
Ceftriaxona 1 g EV C/12H
7. Metronidazol 500mgEV C/8H
8. Metamizol y dimenhidrinato PRN
9. Tramal 1Apm+dimenhidrinato 1Amp+ Nacl 09% 100cc>
EV C/8H
10. Ss hematología y bioquímico de ingreso.
11. Ss Rx de torax AP, RX de Abdomen decúbito y de pie.
12. Ss riesgo quirúrgico.
10/09/2018 (S) Paciente refiere leve dolor en hemiabdomen 1. Reposo
derecho. 2. DB+LAV
(O) FC:100, FR:20,T°: 36,7 3. CFV+BHE+SF+SNG+O2 húmedo para SatO2 >92%
AREG, AREN, AREH, ventilando espontáneamente. 4. NACL 09% a 30gotas
Abdomen: RHA: +, B/D, dolor a la palpación 5. Omeprazol 40mg EV C/24H
profunda en hemiabdomen superior derecha 6. Ceftriaxona 1 g EV C/12H
(hipocondrio derecho) 7. Metronidazol 500mgEV C/8H
Neurológico: ECG: 15pts 8. Metamizol y dimenhidrinato PRN
(A) Paciente varón de 81 años, sin comorbilidades 9. Tramal 1Apm+dimenhidrinato 1Amp+ Nacl 09% 100cc>
previas con diagnostico de tumoración quística EV C/8H
hepática, con signos vitales estable. 10. Ss ecografía abdominal y RQ
(P) Seguir indicaciones medicas.
FECHA EVOLUCIONES INDICACIONES
11/09/2018 (S) Paciente refiere leve dolor en hemiabdomen derecho. 1. Reposo relativo
(O) FC:90, FR:20,T°: 36,8 2. DB+LAV
Abdomen: RHA: +, B/D, dolor a la palpación profunda en 3. CFV+BHE+SF+SNG+O2 húmedo para SatO2 >92%
hemiabdomen superior derecha , se evidencia aumento de 4. CS
tamaño del lado derecho. 5. Omeprazol 40mg EV C/24H
(A) En su 3er día de hospitalización, y no tener agente 6. Dextrosa 5% 1l+ KCL 20% (2)+ gluconato de CA 10%(1)
etiológico se le solicita exámenes auxiliares como western blot > EV 20 gotas
para hidatidosis hepática. 7. Metamizol y dimenhidrinato PRN
(P) Continuar ATB. 8. Tramal 1Apm+dimenhidrinato 1Amp+ Nacl 09% 100cc>
EV C/8H
9. Ss western blot para hidatidosis, CEA,CA19.9
12/09/2018 S) Paciente refiere leve dolor en hemiabdomen derecho. 1. IDEM el día anterior.
(O) FC:82, FR:20,SatO2: 98%, PA: 100/60 2. Medición de la PIA
Abdomen: RHA: +, B/D, dolor a la palpación profunda en 3. Ss HTO, HM, G,U,CR, TPT, Aga y e, plaquetas, Proteinas
totales y fraccionadas, BT y Fx , TGO, TGP
hemiabdomen superior derecha , se evidencia aumento de
4. Provide Gold 30cc VO C/8H
tamaño del lado derecho. 5. Ss: riesgo cardiológico y neumologico
(A) Se agrega a western blot,marcadores CEA y CA19.9
(P) Continuar ATB.
13/09/2018 (S) Paciente refiere leve dolor en hemiabdomen derecho, 1. Reposo relativo
refiere no realizar deposición. 2. DB+LAV
(O) FC:8, FR:20,T° 36.8 3. CFV+BHE+SF
4. CS
(A)Se indica medición de la PIA, obteniendo un valor de
5. Omeprazol 40mg EV C/24H
20cmH20(equivale a 14,7 mmhg) grado I de aumento de 6. Dextrosa 5% 1l+ KCL 20% (2)+ gluconato de CA 10%(1) > EV
presión abdominal, se le indica además lactulosa, se obtiene 20 gotas
riesgo quirúrgica de II/IV 7. Metamizol y dimenhidrinato PRN
(P) A espera de exámenes de lab. Solicitados. 8. Ss Rx torax AP
9. Provide Gold 30cc VO C/8H
10. Metoclopramida 10mg EV C/8H
11. Lactulosa 15cc VO C/12H
12. Insitir PCR y VSG
FECHA EVOLUCIONES INDICACIONES
14/09/2018 (S) Paciente refiere leve dolor en hemiabdomen 1. Reposo relativo
derecho,ya realiza deposiciones. 2. DB+LAV
12:00 3. CFV+BHE+SF
(O) FC:86, FR:19,SatO2: 98%, PA: 100/60, T° 36.8 4. CS
(A) cuenta con riesgo quirúrgico y neumológico; PIA 5. Omeprazol 40mg EV C/24H
normal 6. Metamizol y dimenhidrinato PRN
(P) Seguir indicaciones Medicas. 7. Provide Gold 30cc VO C/8H
8. Metoclopramida 10mg EV C/8H
9. Lactulosa 15cc VO C/12H
10. Insitir PCR y VSG y exámenes: Western Blot, CEA, CA19.9.
35
Clinical management of polycystic liver
disease
René M.M. van Aerts, Liyanne F.M. van de Laarschot, Jesus M. Banales, Joost P.H.
Drenth
36
37
Management of Giant Liver Cysts
Mathew J. Mazoch, B.S., Hany Dabbous, M.D., Hosein Shokouh-Amiri, M.D., Gazi B.
Zibari, M.D
38
Background
Liver cysts are often asymptomatic. Symptomatic liver cysts are uncommon and can be managed by
percutaneous aspiration, laparoscopic/open marsupialization, or resection. Our aim is to review our experience
with management of giant liver cysts (GLC).
Results
The mean hospital stay for laparoscopic marsupialization was 5.57 d compared with 9.2 d for open procedure.
Three (18.7%) postoperative complications (bile leak, recurrence, bleeding) occurred in the laparoscopic group,
and one (20%) bile leak in the open group, with a mean follow-up of 41 mo.
Conclusion
Laparoscopic marsupialization of GLC is as effective and safe as open procedures in preventing cyst recurrence
regardless of cyst size and location, and affords a relatively shorter hospital stay.
39
The Management of Liver Cysts
A. Castillo, S.L. Orloff
40
Background:
Liver Cystic lesions including simple liver cysts, polycystic liver disease, cystadenomas and echinococcal cysts are
commonly encountered benign lesions. Their incidence vary from 0.01% to 3–5%. Liver cysts are often found
during workup of other abdominal diseases and are usually asymptomatic, but when symptoms exist they are due
to size, vital structure compression, abnormal liver enzymes, bleeding, and infection. Complications (hemorrhage,
infection, torsion, rupture, biliary obstruction, or portal hypertension) are more common in giant cysts (>10 cm).
Technique:
After a hockey stick incision, liver mobilization of the desired lobe is done. In giant cysts, initial decompression with
a purse-string sutured gallbladder trocar is warranted. Fluid is sent for cytologic analysis/culture. After mobilization
and assessment of vasculature and biliary tree proximity with intra-operative ultrasound, the cyst(s) in question are
approached. Aspiration by a small fenestration, then partial cyst wall resection (approximately 50%) with linear
staplers is performed to prevent wall regrowth. Biliary communications are assessed, over-sewn with 5-0 Maxon,
then sclerosis with lap pads soaked in a mix of betadine/5% hydrogen peroxide, or 70% ETOH, for 10 minutes per
cavity, careful protection of surrounding tissues is done.
Conclusion:
Percutaneous/laparoscopic cyst aspiration or simple fenestration have a high rate of recurrence (up to 85% in
polycystic liver disease and 29% in simple cyst). Our 20 year experience of >150 cyst treated shows a single
recurrence attributed to a complex biliary cystadenoma. Aspiration, partial resection, marsupialization and sclerosis
of liver cysts is an effective and long-term solution to a commonly encountered problem.
41
Gracias
42